Takeda Pharmaceutical CoMEX:TAK N 67 OCF Yield % is 13.15 as of Jun. 24, 2026, which is 10% above its 10-year median of 11.99. GuruFocus rates MEX:TAK N with a GF Score™ of 67/100 and a GF Value™ of MXN289.17. The stock has 6 warning signs investors should review. Among 1,005 Drug Manufacturers companies, Takeda Pharmaceutical Co ranks better than 85.67% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Takeda Pharmaceutical Co OCF Yield % Related Terms
Takeda Pharmaceutical Co OCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Takeda Pharmaceutical Co's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Takeda Pharmaceutical Co OCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Takeda Pharmaceutical Co's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Takeda Pharmaceutical Co's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Takeda Pharmaceutical Co (MEX:TAK N) has a OCF Yield % of 13.15 as of Jun. 24, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Takeda Pharmaceutical Co and its competitors. This is 10% above median its historical median of 11.99. According to the industry distribution chart, Takeda Pharmaceutical Co ranks #144 out of 1005 companies in the Drug Manufacturers industry, placing it in the top 14.3%.
Is Takeda Pharmaceutical Co's OCF Yield % too high?
Takeda Pharmaceutical Co's current OCF Yield % of 13.15 is 10% above median its 10-year median of 11.99. The Drug Manufacturers industry median OCF Yield % is 3.54. Takeda Pharmaceutical Co's value of 13.15 is 271.5% above this industry median. Based on the distribution chart, Takeda Pharmaceutical Co ranks #144 out of 1005 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Takeda Pharmaceutical Co has a GF Score™ of 67/100, reflecting its overall financial health beyond just this single metric.
How does Takeda Pharmaceutical Co's OCF Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Takeda Pharmaceutical Co ranks #144 out of 1005 companies for OCF Yield %. This places Takeda Pharmaceutical Co in the top 14% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 3.54. Takeda Pharmaceutical Co's value of 13.15 is 271.5% above this benchmark. While the company's 10-year median is 11.99 vs. the industry median of 3.54, Takeda Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.54, based on 1,005 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Takeda Pharmaceutical Co's current OCF Yield % of 13.15 is 271.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Takeda Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Takeda Pharmaceutical Co's current OCF Yield % is 13.15, which is 10% above median its own 10-year median of 11.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Takeda Pharmaceutical Co stock overvalued right now?
Takeda Pharmaceutical Co (MEX:TAK N) has a current OCF Yield % of 13.15. The stock's GF Value™ is MXN289.17, compared to a current price of MXN320.00 — trading 10.7% above its estimated fair value. The current OCF Yield % is 13.15, which is 10% above median its 10-year median of 11.99 and 271.5% above the Drug Manufacturers industry median of 3.54. Takeda Pharmaceutical Co's overall GF Score™ is 67/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Takeda Pharmaceutical Co (MEX:TAK N), the current OCF Yield % is 13.15 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Takeda Pharmaceutical Co (MEX:TAK N) Overvalued in 2026?
Based on GuruFocus' analysis, Takeda Pharmaceutical Co stock appears to be overvalued.
The current stock price of MXN320.00 is trading 10.7% above its estimated GF Value™ of MXN289.17.
Key valuation signals for MEX:TAK N:
OCF Yield %: 13.15 (10% above median its 10-year median of 11.99)
GF Value™: MXN289.17 vs. price of MXN320.00 (10.7% above fair value)
Industry Position: 271.5% above the Drug Manufacturers median (#144 of 1005)
No single metric tells the full story. See the MEX:TAK N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with about 50% from the US, 10% from Japan, 25% from Europe, and 15% from Canada.
67GF Score
Get the complete analysis for MEX:TAK N
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:TAK N has been successfully added to your 
